BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 37068331)

  • 1. Sex-dependent PD-L1/sPD-L1 trafficking in human endothelial cells in response to inflammatory cytokines and VEGF.
    Baggio C; Ramaschi GE; Oliviero F; Ramonda R; Sfriso P; Trevisi L; Cignarella A; Bolego C
    Biomed Pharmacother; 2023 Jun; 162():114670. PubMed ID: 37068331
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Soluble forms of PD-L1 and PD-1 as prognostic and predictive markers of sunitinib efficacy in patients with metastatic clear cell renal cell carcinoma.
    Montemagno C; Hagege A; Borchiellini D; Thamphya B; Rastoin O; Ambrosetti D; Iovanna J; Rioux-Leclercq N; Porta C; Negrier S; Ferrero JM; Chamorey E; Pagès G; Dufies M
    Oncoimmunology; 2020 Nov; 9(1):1846901. PubMed ID: 33299657
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heterogeneous requirement of IkappaB kinase 2 for inflammatory cytokine and matrix metalloproteinase production in rheumatoid arthritis: implications for therapy.
    Andreakos E; Smith C; Kiriakidis S; Monaco C; de Martin R; Brennan FM; Paleolog E; Feldmann M; Foxwell BM
    Arthritis Rheum; 2003 Jul; 48(7):1901-12. PubMed ID: 12847684
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PD-1/PD-L1 pathway activation restores the imbalance of Th1/Th2 and treg/Th17 cells subtypes in immune thrombocytopenic purpura patients.
    Wu D; Liu Y; Pang N; Sun M; Wang X; Haridia Y; Zhao F; Qin Y; Fan W; Guo X; Ding J
    Medicine (Baltimore); 2019 Oct; 98(43):e17608. PubMed ID: 31651870
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum levels of soluble programmed death-ligand 1 (sPD-L1) in patients with primary central nervous system diffuse large B-cell lymphoma.
    Cho I; Lee H; Yoon SE; Ryu KJ; Ko YH; Kim WS; Kim SJ
    BMC Cancer; 2020 Feb; 20(1):120. PubMed ID: 32054467
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma sPD-L1 and VEGF levels are associated with the prognosis of NSCLC patients treated with combination immunotherapy.
    Dong C; Hui K; Gu J; Wang M; Hu C; Jiang X
    Anticancer Drugs; 2024 Jun; 35(5):418-425. PubMed ID: 38386011
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevated Soluble PD-L1 in Pregnant Women's Serum Suppresses the Immune Reaction.
    Okuyama M; Mezawa H; Kawai T; Urashima M
    Front Immunol; 2019; 10():86. PubMed ID: 30833943
    [No Abstract]   [Full Text] [Related]  

  • 8. The correlation and prognostic value of serum levels of soluble programmed death protein 1 (sPD-1) and soluble programmed death-ligand 1 (sPD-L1) in patients with hepatocellular carcinoma.
    Chang B; Huang T; Wei H; Shen L; Zhu D; He W; Chen Q; Zhang H; Li Y; Huang R; Li W; Wu P
    Cancer Immunol Immunother; 2019 Mar; 68(3):353-363. PubMed ID: 30506460
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Soluble PD-L1 as a Biomarker in Malignant Melanoma Treated with Checkpoint Blockade.
    Zhou J; Mahoney KM; Giobbie-Hurder A; Zhao F; Lee S; Liao X; Rodig S; Li J; Wu X; Butterfield LH; Piesche M; Manos MP; Eastman LM; Dranoff G; Freeman GJ; Hodi FS
    Cancer Immunol Res; 2017 Jun; 5(6):480-492. PubMed ID: 28522460
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Programmed cell death protein 1 and its ligands regulate immune balance in allergic rhinitis].
    Wen SL; Li F; Zhao F; Zuo JJ; Deng YQ; Zhang W; Tao ZZ
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2020 Apr; 55(4):384-390. PubMed ID: 32306637
    [No Abstract]   [Full Text] [Related]  

  • 11. Human umbilical vein endothelial cells promote the inhibitory activation of CD4(+)CD25(+)Foxp3(+) regulatory T cells via PD-L1.
    Chen WJ; Hu XF; Yan M; Zhang WY; Mao XB; Shu YW
    Atherosclerosis; 2016 Jan; 244():108-12. PubMed ID: 26615520
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Mechanism on moxibustion for rheumatoid arthritis based on PD-1/PD-L1 signaling pathway].
    Zhong YM; Wu F; Luo XC; Chen Y; Ren JG; Yang X; Ma WB; Zhou HY
    Zhongguo Zhen Jiu; 2020 Sep; 40(9):976-82. PubMed ID: 32959594
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The interaction between the soluble programmed death ligand-1 (sPD-L1) and PD-1
    Li X; Du H; Zhan S; Liu W; Wang Z; Lan J; PuYang L; Wan Y; Qu Q; Wang S; Yang Y; Wang Q; Xie F
    Front Immunol; 2022; 13():830606. PubMed ID: 35935985
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unbalanced expression of membrane-bound and soluble programmed cell death 1 and programmed cell death ligand 1 in systemic juvenile idiopathic arthritis.
    Cai L; Zhang C; Wu J; Zhou W; Chen T
    Clin Immunol; 2021 Aug; 229():108800. PubMed ID: 34289424
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune checkpoint activity exacerbate renal interstitial fibrosis progression by enhancing PD-L1 expression in renal tubular epithelial cells.
    Zhang Y; Mi X; Zhang Y; Li J; Qin Y; He P; Zhao Y; Su B; He L
    Transl Res; 2024 Sep; 271():52-67. PubMed ID: 38723861
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cellular and soluble immune checkpoint signaling forms PD-L1 and PD-1 in renal tumor tissue and in blood.
    Keber CU; Derigs M; Schultz C; Wegner M; Lingelbach S; Wischmann V; Hofmann R; Denkert C; Hegele A; Hänze J
    Cancer Immunol Immunother; 2022 Oct; 71(10):2381-2389. PubMed ID: 35184226
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gender differences and pharmacological regulation of angiogenesis induced by synovial fluids in inflammatory arthritis.
    Baggio C; Boscaro C; Oliviero F; Trevisi L; Ramaschi G; Ramonda R; Bolego C; Cignarella A
    Biomed Pharmacother; 2022 Aug; 152():113181. PubMed ID: 35653890
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Smoking Is Associated With Low Levels of Soluble PD-L1 in Rheumatoid Arthritis.
    Wasén C; Erlandsson MC; Bossios A; Ekerljung L; Malmhäll C; Töyrä Silfverswärd S; Pullerits R; Lundbäck B; Bokarewa MI
    Front Immunol; 2018; 9():1677. PubMed ID: 30140263
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Higher preoperative serum levels of PD-L1 and B7-H4 are associated with invasive and metastatic potential and predictable for poor response to VEGF-targeted therapy and unfavorable prognosis of renal cell carcinoma.
    Fukuda T; Kamai T; Masuda A; Nukui A; Abe H; Arai K; Yoshida K
    Cancer Med; 2016 Aug; 5(8):1810-20. PubMed ID: 27292320
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Soluble programmed cell death protein 1 (sPD-1) and the soluble programmed cell death ligands 1 and 2 (sPD-L1 and sPD-L2) in lymphoid malignancies.
    Mortensen JB; Monrad I; Enemark MB; Ludvigsen M; Kamper P; Bjerre M; d'Amore F
    Eur J Haematol; 2021 Jul; 107(1):81-91. PubMed ID: 33721375
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.